Jacqualyn A Fouse

Director · 3 filings · Latest: Jun 18, 2026

AGIOS PHARMACEUTICALS, INC.

INCYTE CORP

MADRIGAL PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
AGIO	Jacqualyn A Fouse	Director	Jun 18, 2026	Option Exercise	$0.00	2,816	—	154,156	Jun 23 9:22 PM
AGIO	FOUSE JACQUALYN A	—	Apr 8, 2025	Proposed Sale	$25.90	7,497	$194.2K	—	Apr 8 9:58 PM